Literature DB >> 8675584

Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome.

G Norbiato1, M Bevilacqua, T Vago, M Clerici.   

Abstract

Some patients with acquired immunodeficiency syndrome (AIDS) develop glucocorticoid resistance characterized by low receptor affinity (Kd) for glucocorticoids in mononuclear, cells and high values of ACTH and cortisol. As glucocorticoids regulate interferon-alpha (IFN alpha) production, we hypothesized that IFN alpha, a cytokine produced predominantly by monocytes in AIDS, should be increased in cortisol-resistant AIDS, attributing the lack of cortisol inhibition to IFN alpha production. Therefore, we examined glucocorticoid receptor characteristics on monocytes by [3H]dexamethasone binding and measured IFN alpha, cortisol, and ACTH in AIDS patients with (AIDS-GR) or without glucocorticoid resistance (AIDS-C) and controls (C). Monocytes of AIDS-GR patients had a receptor Kd of 10.5 +/- 4.2 nmol/L that was higher than that in the AIDS-C group (2.9 +/- 0.8 nmol/L) and normal subjects (2.0 +/- 0.8 nmol/L; P < 0.01). IFN alpha levels were increased in the AIDS-GR group (17 +/- 6 vs. 4 +/- 1 U/mL in the AIDS-C group and 2 +/- 0.5 U/mL in the C group; P < 0.01). Correlations were found between plasma IFN alpha and receptor Kd on monocytes of AIDS-GR (r = 0.77) and between IFN alpha and plasma cortisol in the same group (r = 0.74). The poly(I)-poly(C)-induced IFN alpha production by monocytes was inhibited by glucocorticoids in the C and AIDS-C groups (approximately 80% inhibition in both groups); the effect was reversed by the receptor antagonist RU-38486. By contrast, glucocorticoids failed to inhibit IFNalpha production from AIDS-GR monocytes (approximately 20% inhibition). In conclusion, elevated IFN alpha levels in AIDS-GR may be due to the lack of inhibitory effect of cortisol on IFN alpha production due to cortisol resistance in monocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675584     DOI: 10.1210/jcem.81.7.8675584

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  In vitro effect of dexamethasone phosphate on hematopoietic progenitor cells in preterm infants.

Authors:  P Papoff; R D Christensen; J Harcum; Y Li
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

2.  The type I interferon signaling pathway is a target for glucocorticoid inhibition.

Authors:  Jamie R Flammer; Jana Dobrovolna; Megan A Kennedy; Yurii Chinenov; Christopher K Glass; Lionel B Ivashkiv; Inez Rogatsky
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

Review 3.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

4.  Personality and serotonin transporter genotype interact with social context to affect immunity and viral set-point in simian immunodeficiency virus disease.

Authors:  John P Capitanio; Kristina Abel; Sally P Mendoza; Shelley A Blozis; Michael B McChesney; Steve W Cole; William A Mason
Journal:  Brain Behav Immun       Date:  2007-08-23       Impact factor: 7.217

5.  Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells.

Authors:  Fang Hu; Thaddeus W W Pace; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2009-01-08       Impact factor: 7.217

6.  Glucocorticoid receptor dimers control intestinal STAT1 and TNF-induced inflammation in mice.

Authors:  Marlies Ballegeer; Kelly Van Looveren; Steven Timmermans; Melanie Eggermont; Sofie Vandevyver; Fabien Thery; Karen Dendoncker; Jolien Souffriau; Jolien Vandewalle; Lise Van Wyngene; Riet De Rycke; Nozomi Takahashi; Peter Vandenabeele; Jan Tuckermann; Holger M Reichardt; Francis Impens; Rudi Beyaert; Karolien De Bosscher; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  J Clin Invest       Date:  2018-06-25       Impact factor: 14.808

7.  Human immunodeficiency virus endocrinopathy.

Authors:  Uma Sinha; Nilanjan Sengupta; Prasanta Mukhopadhyay; Keshab Sinha Roy
Journal:  Indian J Endocrinol Metab       Date:  2011-10

8.  Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity.

Authors:  Heng Yang; Lin Xia; Jian Chen; Guido Kroemer; Yuting Ma; Shuqing Zhang; Vincent Martin; Qingqing Li; Shangqing Lin; Jinfeng Chen; Joseph Calmette; Min Lu; Lingyi Fu; Jie Yang; Zhizhong Pan; Kuai Yu; Jingjing He; Eric Morand; Géraldine Schlecht-Louf; Roman Krzysiek; Laurence Zitvogel; Boxi Kang; Zeming Zhang; Andrew Leader; Penghui Zhou; Laurence Lanfumey; Minxin Shi
Journal:  Nat Med       Date:  2019-09-09       Impact factor: 53.440

Review 9.  Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids.

Authors:  Hélène Prigent; Virginie Maxime; Djillali Annane
Journal:  Crit Care       Date:  2004-05-25       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.